IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALTOMARE, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.132
NA - Nord America 871
EU - Europa 495
SA - Sud America 416
AF - Africa 34
OC - Oceania 4
Totale 2.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 825
SG - Singapore 504
BR - Brasile 350
CN - Cina 227
DE - Germania 123
HK - Hong Kong 123
VN - Vietnam 111
IT - Italia 80
RU - Federazione Russa 66
TR - Turchia 54
GB - Regno Unito 53
CZ - Repubblica Ceca 32
CA - Canada 27
IN - India 26
BD - Bangladesh 25
AT - Austria 24
UA - Ucraina 24
FI - Finlandia 22
AR - Argentina 20
EC - Ecuador 17
FR - Francia 13
MX - Messico 13
PL - Polonia 13
ID - Indonesia 11
JP - Giappone 11
NL - Olanda 11
SE - Svezia 10
ZA - Sudafrica 10
PY - Paraguay 7
CO - Colombia 6
KE - Kenya 6
BE - Belgio 5
ES - Italia 5
MA - Marocco 5
PE - Perù 5
PK - Pakistan 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
CL - Cile 4
JO - Giordania 4
AZ - Azerbaigian 3
HN - Honduras 3
IQ - Iraq 3
PT - Portogallo 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
ET - Etiopia 2
IE - Irlanda 2
LB - Libano 2
LT - Lituania 2
NO - Norvegia 2
SN - Senegal 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GM - Gambi 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KI - Kiribati 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
Totale 2.952
Salva come PNG Salva come JPEG
Città #
Singapore 209
Hong Kong 123
Ashburn 108
Beijing 56
Istanbul 47
Los Angeles 45
New York 44
Ho Chi Minh City 40
Munich 40
Boardman 35
Fairfield 32
Des Moines 30
The Dalles 30
Moscow 28
Nuremberg 28
São Paulo 27
Hanoi 26
Romola 24
Buffalo 21
Houston 21
Woodbridge 21
Chicago 20
San Francisco 20
Redondo Beach 19
Santa Clara 18
Olomouc 17
Shanghai 16
Turku 16
Brno 15
Dallas 15
Rio de Janeiro 14
Denver 13
Mumbai 13
Seattle 13
Vienna 13
London 12
Warsaw 11
Boston 10
Jacksonville 10
Montreal 10
Stockholm 10
Tokyo 10
Wilmington 10
Brooklyn 9
Belo Horizonte 8
Cambridge 8
Charlotte 8
Curitiba 8
Manchester 8
Phoenix 8
Ribeirão Preto 8
Toronto 8
Atlanta 7
Chandler 7
Düsseldorf 7
Frankfurt am Main 7
Orem 7
Helsinki 6
Milan 6
Nairobi 6
Poplar 6
Porto Alegre 6
Brussels 5
Dearborn 5
Goiânia 5
Guayaquil 5
Jinan 5
Johannesburg 5
Lauterbourg 5
Mexico City 5
Ottawa 5
Padova 5
Quito 5
São José dos Campos 5
Tashkent 5
Amman 4
Amsterdam 4
Brasília 4
Cape Town 4
Chennai 4
Cotia 4
Imperatriz 4
Ipatinga 4
Kunming 4
Nanjing 4
Nova Iguaçu 4
Petrolina 4
Princeton 4
Riyadh 4
Santo André 4
Shijiazhuang 4
Ankara 3
Ann Arbor 3
Baku 3
Bari 3
Bergamo 3
Biên Hòa 3
Buenos Aires 3
Changsha 3
Criciúma 3
Totale 1.634
Salva come PNG Salva come JPEG
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 189
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 179
AMYPAD Diagnostic and Patient Management Study: Rationale and design 77
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study 77
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 71
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 71
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 70
Applying the ATN scheme in a memory clinic population: The ABIDE project 70
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 67
Brain atrophy in Alzheimer's Disease and aging 65
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 65
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 64
Plasma biomarkers for Alzheimer's disease: A field-test in a memory clinic 63
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial 62
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 61
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 61
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 61
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 60
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 60
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease 58
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 58
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 58
Clinical utility of FDG-PET for the clinical diagnosis in MCI 57
Medial temporal lobe atrophy and posterior atrophy scales normative values 57
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years 57
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design 56
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 55
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised 55
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 54
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 54
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults with Subjective Cognitive Decline 53
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 52
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact 52
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 51
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 51
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 51
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 50
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 50
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study 48
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 48
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 47
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 47
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 44
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies 43
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives 39
Multitracer model for staging cortical amyloid deposition using PET imaging 39
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project 35
Feasibility of a standard cognitive assessment in European academic memory clinics 33
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study 32
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey 28
Totale 3.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 2 2 3 3 3 4 1
2021/202222 1 0 1 2 0 0 1 2 5 2 2 6
2022/202316 3 1 0 3 1 5 0 0 3 0 0 0
2023/2024214 3 2 7 0 0 11 2 1 5 55 16 112
2024/20251.152 31 1 57 148 76 79 137 17 189 84 195 138
2025/20261.395 221 367 201 362 234 10 0 0 0 0 0 0
Totale 3.005